Abstract
As part of an ongoing effort to develop new thalidomide analogues as antiinflammatory lead-candidates, this paper describes the synthesis and antiinflammatory activity of novel N-phenyl-phthalimide functionalized derivatives (4a-d, 5a,b, 6a,b). The target compounds were assayed in an acute lung inflammatory model and all compounds were able to inhibit TNF-alpha production and subsequent neutrophil recruitment in the LPS-acute lung inflammatory model.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / chemical synthesis*
-
Anti-Inflammatory Agents / pharmacology
-
Chemotaxis / drug effects
-
Drug Design
-
Inflammation / chemically induced
-
Inflammation / drug therapy
-
Lipopolysaccharides / pharmacology
-
Lung Diseases / chemically induced
-
Lung Diseases / drug therapy
-
Mice
-
Neutrophils / drug effects
-
Phthalimides / chemical synthesis*
-
Phthalimides / pharmacology
-
Structure-Activity Relationship
-
Thalidomide / chemistry
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Anti-Inflammatory Agents
-
Lipopolysaccharides
-
Phthalimides
-
Tumor Necrosis Factor-alpha
-
Thalidomide